Drug Shortage Report for TARO-CLOMIPRAMINE
Report ID | 150642 |
Drug Identification Number | 02497514 |
Brand name | TARO-CLOMIPRAMINE |
Common or Proper name | CLOMIPRAMINE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CLOMIPRAMINE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | N06AA |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-25 |
Estimated end date | 2022-01-21 |
Actual end date | 2021-12-20 |
Shortage status | Resolved |
Updated date | 2022-01-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-01-06 | French | Compare |
v5 | 2022-01-06 | English | Compare |
v4 | 2022-01-06 | French | Compare |
v3 | 2022-01-06 | English | Compare |
v2 | 2021-12-07 | French | Compare |
v1 | 2021-12-07 | English | Compare |
Showing 1 to 6 of 6